STOCKWATCH
·
Specialty Chemicals
Acquisitions26 Nov 2025, 12:29 pm

Camlin Fine Sciences Adjusts Timetable for Vinpai Acquisition Completion and OPAS Filing

AI Summary

Camlin Fine Sciences Ltd. has announced an adjustment to the timetable for completing the acquisition of a majority stake in Vinpai, a French société anonyme. The allotment of CFSL Consideration Shares against delivery of the Block Acquisition is now set for November 30, 2025, subject to the delivery of the Block Acquisition. The filing of the draft OPAS by CFSL with the French stock market authority is expected in the mid of December 2025. This adjustment is due to the delay in obtaining Indian regulatory approvals, which were received on November 18, 2025, instead of the initially expected date of November 12, 2025.

Key Highlights

  • Camlin Fine Sciences Ltd. has adjusted the timetable for completing the acquisition of a majority stake in Vinpai.
  • The allotment of CFSL Consideration Shares against delivery of the Block Acquisition is now set for November 30, 2025.
  • The filing of the draft OPAS by CFSL with the French stock market authority is expected in the mid of December 2025.
  • The delay in obtaining Indian regulatory approvals has led to this adjustment in the timetable.
  • The Indian regulatory approvals were obtained on November 18, 2025, instead of the initially expected date of November 12, 2025.
CAMLINFINE
Specialty Chemicals
CAMLIN FINE SCIENCES LTD.

Price Impact